KinshasaNo approved therapy exists for this Ebola strain.
Approved Ebola treatments target only the Zaire species, leaving Bundibugyo, behind the current outbreak, without any authorized drug.
Jean-Jacques Muyembe, DRC’s leading Ebola scientist, says a monoclonal antibody against Bundibugyo is now in development, no timeline given.
Sources: SciDev.Net